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The Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 
newly developed the first Korean Guideline on the Diagnosis and Treatment of Obesity in Children and Adolescents 
to deliver an evidence-based systematic approach to childhood obesity in South Korea. The following areas were 
systematically reviewed, especially on the basis of all available references published in South Korea and worldwide, 
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and new guidelines were established in each area with the strength of recommendations based on the levels of evidence: 
1) definition and diagnosis of overweight and obesity in children and adolescents; 2) principles of treatment of pediatric 
obesity; 3) behavioral interventions for children and adolescents with obesity, including diet, exercise, lifestyle, and 
mental health; 4) pharmacotherapy; and 5) bariatric surgery.
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INTRODUCTION
The prevalence of childhood obesity is dramati-
cally increasing in South Korea, which has been as-
sociated with changes in lifestyle, such as Westernized 
high-calorie, high-fat diet with sugar-sweetened 
beverages, sedentary lifestyles, and decreased phys-
ical activity [1]. In a recent report, the prevalence of 
obesity in children aged below 6 years increased 
from 1.4% in 2008 to 2.8% in 2015, and that in chil-
dren and adolescents aged 7 to 18 years rapidly in-
creased from 8.4% in 2008 to 14.3% in 2016 [1]. 
Accordingly, the prevalence of obesity-related phys-
ical, psychosocial, and metabolic complications, 
such as metabolic syndrome and non-alcoholic fatty 
liver disease (NAFLD), is also increasing in Korean 
children and adolescents [2].
Childhood obesity may persist lifelong if not treat-
ed properly; it can lead to adulthood obesity and a va-
riety of metabolic and cardiovascular complications 
later in life. Thus, pediatric obesity is regarded as one 
of the priority health issues, and the treatment of 
childhood obesity and its complications may be one 
of the most effective strategies to reducing morbid-
ities and mortalities and to saving hospital costs later 
in life.
Strict guidelines or consensus statements on the 
diagnosis and treatment of pediatric obesity have 
been published and updated in Western countries. 
However, to date, there are no evidence-based guide-
lines on pediatric obesity in Asia, including South 
Korea. Therefore, the Committee on Pediatric 
Obesity of the Korean Society of Pediatric Gastroen-
terology, Hepatology and Nutrition (KSPGHAN) de-
veloped an evidence-based guideline on the diag-
nosis and treatment of obesity in children and ado-
lescents, to deliver a systematic approach to child-
hood obesity in South Korea.
METHODS 
To develop the first evidence-based clinical prac-
tice guideline on the diagnosis and treatment of obe-
sity in children and adolescents in South Korea, the 
Committee on Pediatric Obesity of the KSPGHAN es-
tablished a Guideline Task Force (TF) in March 2017. 
This TF was composed of pediatric gastroenterologists 
with an expertise in clinical nutrition, as well as pe-
diatric neuropsychiatrists, clinical nutrition special-
ists, and exercise specialists. Experts from these 
areas were designated to each TF subgroup accord-
ing to their professional specialty. 
A systematic protocol for the establishment of an 
evidence-based guideline for the diagnosis and treat-
ment of obesity in children and adolescents was pre-
pared and established through regular TF meetings. 
The basic format of the guideline was determined to 
encompass a total of eight topics within five different 
sections as follows: 
1) Definition and diagnosis of overweight and 
obesity in children and adolescents
2) Principles of the treatment of pediatric obesity
3) Behavioral interventions for children and ado-
lescents with obesity
(1) Diet
(2) Exercise
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(3) Lifestyle
(4) Mental health
4) Pharmacotherapy in children and adolescents 
with obesity
5) Bariatric surgery in children and adolescents 
with obesity
Each TF working subgroup searched all references 
related to pediatric obesity in each assigned field 
through PubMed search using MeSH (Medical 
Subject Headings) terms, as well as all available ref-
erences published in South Korea using appropriate 
systematic search strategies. These references in-
cluded randomized controlled trials (RCTs), ob-
servational studies (e.g., case-control studies, pro-
spective and retrospective cohort studies, case series 
studies), meta-analyses, systematic reviews, and 
previous obesity guidelines or position papers or con-
sensuses on both children and adults with obesity 
through the entire period using a last search date of 
September 30, 2018. Subsequently, each TF sub-
group reviewed, analyzed, and summarized all re-
lated documents and references in each field.
To establish a systematic evidence-based guide-
line, the strength of evidence and grade of recom-
mendation were determined for each recom-
mendation according to a previously adapted classi-
fication system for evidence-based guidelines (Table 
1) [3-5]. The strength of evidence was classified from 
level I to level V based on the value of the evidence in 
the literature, including systematic review, 
meta-analysis, and scientific papers: RCTs, well-de-
signed trials, consensus studies, and opinions of re-
search groups, respected authorities, and expert 
committees. Level I represents the strongest 
evidence. 
The grade of recommendation was determined ac-
cording to the strength of evidence and importance 
of the recommendation. Levels I to III evidence were 
decided to correspond to Grades A to C of recom-
mendations, which were regarded as highly recom-
mended or recommended, respectively. Levels IV 
and V recommendations for were basically regarded 
as Grade D; the final grade was decided through vot-
ing consensus of the entire TF. A total of three 
face-to-face meetings were held in Seoul and Jeju 
Island and 14 online video meetings to achieve con-
sensus on all of the recommendations. All recom-
mendations were voted on and accepted when 100% 
agreement was achieved.
1. Definition and diagnosis of overweight 
and obesity in children and adolescents 
1-1. We suggest to use the Korean National Growth 
Charts body mass index (BMI) percentile to diag-
nose overweight and obesity in children and ado-
lescents over two years of age. (Strength of evi-
dence, level III; grade of recommendation, C)
1-2. We suggest to diagnose overweight when the 
BMI is above the 85th but ＜95th percentile for age 
and sex, and obesity when the BMI is above the 
95th percentile in children and adolescents ＞2 
years of age. (Strength of evidence, III; grade of rec-
ommendation, C)
1-3. We suggest that children ＜24 months of age 
be diagnosed as overweight if weight for height is 
above the 95th percentile on the Korean National 
Growth Charts, which introduced the World Health 
Organization (WHO) growth standards in this age 
group, as the Korean Society of Pediatrics accepts 
this basis as valid. (Strength of evidence, V; grade of 
recommendation, C, based on committee voting)
1-4. We recommend to assess comorbidities: 
NAFLD, dyslipidemia, hypertension, prediabetes, 
type II diabetes mellitus (DM), polycystic ovary 
syndrome, obstructive sleep apnea, and psychoso-
cial problems. (Strength of evidence, V; grade of 
recommendation, A, based on committee voting)
1-1. We suggest to use the Korean National 
Growth Charts BMI percentile to diagnose over-
weight and obesity in children and adolescents over 
two years of age. (Strength of evidence, level III; 
grade of recommendation, C)
The Korean National Growth BMI charts are ac-
cepted as valid for Korean children and adolescents 
over two years of age and provide a means for de-
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Table 1. The Strength of Evidence and the Grade of Recommendation in Support of the Recommendations Formulated and 
Established in the KSPGHAN Clinical Practice Guideline on the Diagnosis and Treatment of Pediatric Obesity [5]
Strength of 
evidence
Grade of 
recommendation
I Grade A Strong evidence from one or more systematic review(s) of 
well-designed RCTs
Highly recommended
II Grade B Strong evidence from one or more properly designed RCT(s) of 
appropriate size
Recommended
III Grade C Evidence from well-designed clinical trials without randomization, 
comparative study in a single group, cohort study, time series 
study or matched case-control studies
Recommended
IV Grade D Evidence from well-designed clinical trials, non-experimental 
studies from one or more center or research group
The consensus route would 
have to be adopted
V Grade D Opinion of respected authorities, clinical evidence, descriptive 
studies, or reports of experts committees
The consensus route would 
have to be adopted
KSPGHAN: Korean Society of Pediatric Gastroenterology Hepatology and Nutrition, RCT: randomized controlled trial.
termining changes in pediatric obesity prevalence 
[6]. The 2017 Korean National Growth Charts are 
recommended for the evaluation of body size and 
growth of Korean children and adolescents to use in 
practice and in the public health sector in South 
Korea [6].
A systematic review by the United States 
Preventive Services TF reported that the BMI of 
children and adolescents correlate well to the per-
centile of body fat [7]. In 1990s, an expert commit-
tee recommended using BMI for screening over-
weight in children and adolescents [8]. In the 2000 
Centers for Disease Control (CDC) Growth Chart 
and 2011 United Kingdom (UK) Growth Chart 
(http://www.rcpch.ac.uk/growthcharts), the BMI chart 
is available for children and adolescents aged 2 to 20 
years [9]. Meanwhile, a considerable proportion of 
boys and girls with relatively normal fat mass appear 
to be misclassified and may be at risk of being over-
weight based on the BMI criteria in a Korean study 
using the Korea National Health and Nutrition 
Examination Survey; their findings indicated that 
body fat mass and fat-free mass would be helpful for 
complementary assessment [10]. Despite some limi-
tations, BMI is currently the most reasonable meth-
od for diagnosing overweight and obesity in children 
over two years old.
1-2. We suggest to diagnose overweight when 
the BMI is above the 85th but ＜95th percentile for 
age and sex, and obesity when the BMI is above the 
95th percentile in children and adolescents ＞two 
years of age. (Strength of evidence, III; grade of rec-
ommendation, C)
1-3. We suggest that children ＜24 months of age 
be diagnosed as overweight if weight for height is 
above the 95th percentile on the Korean National 
Growth Charts, which introduced the WHO growth 
standards in this age group, as the Korean Society 
of Pediatrics has accepted this standard as valid. 
(Strength of evidence, V; grade of recommendation,  
C, based on committee voting)
The Korean National Growth Chart recently re-
vised the BMI cutoffs of obesity in children and 
adolescents. The criteria of obesity for children aged 
＞2 years have changed from a BMI of ≥95th per-
centile for age and sex or BMI ≥25 kg/m2 to a BMI of 
≥95th percentile for age and sex [6]. When applying 
a new BMI cutoff and a recently developed Korean 
National Growth Chart, a study reported that the 
prevalence of obesity is 10.3% in South Korea [6]. 
These criteria, based on the BMI percentiles, are the 
same as those used in United States of America (US), 
based on the CDC Growth Chart, and in the UK 
(http://www.rcpch.ac.uk/growthcharts) [9,11]. We 
could not find any meta-analysis or systematic re-
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Fig. 1. Stepwise assessment 
and treatment strategies for 
overweight and obesity child-
ren and adolescents. BMI: 
body mass index, NAFLD: non- 
alcoholic fatty liver disease, 
DM: diabetes mellitus, CNS: 
central nervous system.
view to justify applying the adult standards of BMI 
≥25 kg/m2 to children, regardless of risk evaluations 
of comorbidities. In children aged under two years, 
the criteria of overweight were changed from weight 
for age to weight for height in a recent 2017 Korean 
Growth Chart after the introduction of the WHO 
Child Growth Standards [12].
Data suggest that severely obese children and ado-
lescents have a worse risk factor profile compared 
with less obese children. In a large cross-sectional 
and longitudinal study in the US, 59% of children 
with BMI ≥99th percentile had at least two risk fac-
tors, whereas 39% of children with BMI ≥95th per-
centile had at least two risk factors [13]. Consequently, 
expert committees in the US and Italy have sug-
gested BMI ≥99th percentile as severe obesity in 
older children [14,15]. In another proposed US 
guideline, extreme or class 2 obesity in children is de-
fined as a BMI exceeding 120% of the 95th percentile 
or ＞35 kg/m2, and class 3 obesity to be BMI exceed-
ing 140% of the 95th percentile or ＞40 kg/m2 [11]. 
WHO provides the values of BMI as ≥99th percen-
tile and +3 standard deviations of Z scores [16]. The 
WHO definition for severe obesity differs between 
age groups. The 99th percentile identifies “obesity” 
in the younger age group (0-5 years) and “severe 
obesity” in the older age group (5-18 years). This ap-
proach takes into account the difference in growth 
process between younger and older children. Few 
data are available on the significance of the cutoffs 
for the upper end of the BMI in preschool-aged 
children. Moreover, the WHO cutoffs for severe obe-
sity have not been assessed yet. 
The Korean Growth Chart also provides the curves 
of BMI ≥99th percentile and +3 standard deviations 
of Z scores in its website (http://www.cdc.go.kr/).
1-4. We recommend to assess comorbidities: 
NAFLD, dyslipidemia, hypertension, prediabetes, 
type II DM, polycystic ovary syndrome, obstructive 
sleep apnea, and psychosocial problems. (Strength 
of evidence, V; grade of recommendation, A, based 
on committee voting)
In obese children and adolescents, the assessment 
for comorbidities is recommended (Fig. 1). Table 2 
lists the suggested obesity-related comorbidities and 
their corresponding screening tests [17-22].
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Table 2. Lists of Obesity-Related Comorbidity and Corresponding Screening Tests
Comorbidity Definitions
NAFLD Alanine aminotransferase; ≥26 U/L (boys) and ≥22 U/L (girls)
Ultrasonography, if indicated
Prediabetes HbA1c of 5.7% to 6.5% (39 to 48 mmol/mol)
Fasting plasma glucose; 100 to 125 mg/dL (5.5 to 6.9 mmol/L)
Two-hour plasma glucose; 140 to 199 mg/dL (7.8 to 11.0 mmol/L)
Type 2 DM HbA1c ≥6.5% (≥48 mmol/mol)
Fasting plasma glucose; ≥126 mg/dL (≥7.0 mmol/L)
Two-hour plasma glucose; ≥200 mg/dL (≥11.1 mmol/L) during an oral glucose tolerance test
In a patient with classic symptoms of hyperglycemia, a random plasma glucose; ≥200 mg/dL
Dyslipidemia Fasting triglycerides (mg/dL) (multiply by 0.0113 to convert to mmol/L):
  0-9 y; ＜75 (acceptable), 75-99 (borderline high), ≥100 (high)
  10-19 y; ＜90 (acceptable), 90-129 (borderline high), ≥130 (high)
LDL cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L):
  ＜110 (acceptable), 110-129 (borderline high), ≥130 (high)
Total cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L):
  ＜170 (acceptable), 170-199 (borderline high), ≥200 (high)
HDL cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L):
  ＜40 (low), 40-45 (borderline low), ＞45 (acceptable)
Non-HDL cholesterol (mg/dL) (multiply by 0.0259 to convert to mmol/L) (can be nonfasting)
  ＜120 (acceptable), 120-144 (borderline high), ≥145 (high)
Prehypertension 
and hypertension
3-11 y: (standardized according to sex, age, and height percentile) 
  BP of ＞90th percentile to ＜95th percentile=prehypertension
  BP of ≥95th percentile to ＜99th percentile+5 mmHg=stage 1 HTN 
  BP of ≥99th percentile+5 mmHg=stage 2 HTN
12-17 y: (standardized according to sex, age, and height percentile)
  BP of ＞90th percentile to ＜95th percentile or ＞120/80 mmHg=prehypertension
  BP of ≥95th percentile to ＜99th percentile+5 mmHg=stage 1 HTN
  BP of ≥99th percentile+5 mmHg=stage 2 HTN
PCOS Free and total testosterone and sex hormone binding protein
Ultrasonography, if indicated
Obstructive sleep apnea If there is a positive history, refer to a pulmonologist for nocturnal polysomnography and, if not 
available, overnight oximetry
Psychiatric problem If there is a positive history, refer to a mental health specialist.
NAFLD: non-alcoholic fatty liver disease, DM: diabetes mellitus, HbA1c: hemoglobin A1c, LDL: low density lipoprotein, HDL: high
density lipoprotein, BP: blood pressure, HTN: hypertension, PCOS: polycystic ovary syndrome.
2. Principles of the treatment of pediatric 
obesity
2-1. We recommend a treatment algorithm to help 
physicians determine the appropriate weight man-
agement stage for each patient, on the basis of his or 
her age, BMI percentile, and comorbidities. (Strength 
of evidence, I; grade of recommendation, A)
2-2. We recommend a family-based, compre-
hensive, multidisciplinary team approach to suc-
ceed in behavioral interventions (active vigorous 
physical activity and reduction of inactivity, accom-
panied with calorie-controlled diet) for the treat-
ment of obesity in children. (Strength of evidence, 
I; grade of recommendation, A)
2-3. We recommend that pharmacotherapy and 
bariatric surgery be considered only in patients 
with morbid obesity with major comorbidities after 
a formal program of intensive lifestyle modification 
has failed. (Strength of evidence, V; grade of recom-
mendation, A, based on committee voting)
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2-1. Treatment algorithm to help physicians de-
termine the appropriate weight management stage 
for each patient, on the basis of his or her age, BMI 
percentile, and comorbidities (Strength of evidence, 
I; grade of recommendation, A)
Behavioral interventions for lifestyle modification 
represent the key principle recommended for the 
treatment of overweight and obesity in children and 
adolescents. The following are the staged treatment 
strategies for pediatric obesity according to age and 
BMI percentile [23]:
1) Children aged 2 to 5 years
(1) BMI 85th-94th percentile (overweight)
The weight goal is weight maintenance until 
reaching a BMI below the 85th percentile or 
slowing of weight gain, as indicated by the 
downward deflection in the BMI curve.
(2) BMI 95th-98th percentile (obesity)
The weight goal is weight maintenance until 
reaching a BMI below the 85th percentile; 
however, if weight loss occurs with healthy, 
adequate-energy diet, it should not exceed 
0.5 kg/month. If greater weight loss is noted, 
monitor the patient for causes of excessive 
weight loss.
(3) BMI ≥99th percentile (severe obesity)
The weight goal is gradual weight loss not ex-
ceeding 0.5 kg/month. If greater weight loss 
occurs, monitor the patient for causes of ex-
cessive weight loss.
2) Children aged 6-11 years
(1) BMI 85th-94th percentile (overweight)
The weight goal is weight maintenance until 
reaching a BMI not exceeding the 85th per-
centile or slowing of weight gain, as indicated 
by the downward deflection in the BMI curve. 
(2) BMI 95th-98th percentile (obesity)
The weight goal is weight maintenance until 
reaching a BMI of below the 85th percentile 
or gradual weight loss of approximately 0.5 
kg/month. If greater loss is noted, monitor 
the patient for causes of excessive weight loss. 
(3) BMI ≥99th percentile (severe obesity)
The weight goal is weight loss not exceeding 
the average of 0.9 kg/week. If greater weight 
loss is noted, monitor the patient for causes of 
excessive weight loss. 
3) Adolescents aged 12-18 years
(1) BMI 85th-94th percentile (overweight)
The weight goal is weight maintenance until 
reaching a BMI not exceeding the 85th per-
centile or slowing of weight gain, as indicated 
by the downward deflection in the BMI curve. 
(2) BMI 95th-98th percentile (obesity)
The weight goal is weight loss until reaching a 
BMI below the 85th percentile, with no more 
than an average of 0.9 kg/week. If greater 
weight loss is noted, monitor the patient for 
causes of excessive weight loss. 
(3) BMI ≥99th percentile (severe obesity)
The weight goal is weight loss not exceeding 
the average of 0.9 kg/week. If greater weight 
loss is noted, monitor the patient for causes of 
excessive weight loss. Patients may warrant 
tertiary care evaluation to determine the next 
level of treatment. 
2-2. We recommend a family-based, compre-
hensive, multidisciplinary team approach to succeed 
in behavioral interventions (active vigorous physical 
activity and reduction of inactivity, accompanied 
with calorie-controlled diet) for the treatment of 
obesity in children. (Strength of evidence, I; grade 
of recommendation, A)
The interactions between parents and children 
and parenting styles strongly affect the unhealthy 
lifestyle habits of children [24]. Obese children are 
more likely to be bullied and have fewer friends or 
are less popular among classmates compared with 
thinner peers [25]. Parents, teachers, and friends 
have indicated that youths who are obese are easily 
isolated and have poorer social relationships com-
pared with their counterparts [26]. Those with low 
self-esteem and higher BMIs are more likely to 
smoke and drink alcohol [27]. These children are al-
so less athletic and are not expected to have romantic 
relationships. Thus, they tend to demonstrate teas-
ing, worsening of self-esteem, feeling of loneliness, 
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depression, anxiety, and an introverted personality 
[28].
Data from 133 RCTs enrolling 30,445 patients 
through 16 systemic reviews presented an evidence 
profile for each intervention, including medication, 
surgery, and lifestyle or community-based interven-
tions, in overweight or obese children or adolescents. 
Physical activity interventions decrease systolic 
blood pressure (BP) and fasting glucose (low to mod-
erate quality of evidence). Dietary interventions with 
low-carbohydrate diets have shown an effect in 
terms of BMI reduction (moderate quality of evi-
dence). Educational interventions reduce waist cir-
cumference, BMI, and diastolic BP (low quality of 
evidence). Pharmacological interventions reduce 
BMI (metformin, sibutramine, and orlistat) and 
waist circumference (sibutramine and orlistat) as 
well as increase high-density lipoprotein cholesterol 
(sibutramine) but also raise systolic and diastolic BP 
(sibutramine). Surgical interventions (laparoscopic 
adjustable gastric banding, Roux-en-Y gastric by-
pass, and sleeve gastrectomy) have shown the larg-
est BMI reduction (moderate quality of evidence). 
Combined interventions consisting of dietary mod-
ification, physical activity, behavioral therapy, and 
education significantly reduce systolic and diastolic 
BP, BMI, and triglycerides. Combined parent–child 
and parent-only interventions have similar effects 
on BMI (low quality of evidence) [29].
A school-based intervention reportedly reduces BP 
and body fat in young teenagers. Short-term car-
diovascular health in children-targeted interventions 
showed successful results in demonstrating affected 
physiological variables according to increased time 
spent in moderate to vigorous physical activity at 
school (20 minutes per day in elementary schools, 30 
minutes in middle schools) [30]. Both school-de-
signed workout and adult supervision in physical ac-
tivities affected the amount of physical activity of 
sixth to eighth graders participating in their free 
time [31].
A systemic analysis of 24 reports reviewing 15 
studies showed strong evidence that reduced screen 
time and enhanced physical activity could prevent 
obesity. Data from 11,000 preschool children 4 to 6 
years of age linked increased caloric intake from 
snacks and sugar-sweetened beverages with in-
creased screen time [32]. Another study revealed 
that decreasing screen time also decreases sedentary 
time [33]. A two-generation study associated in-
creased BMI with two hours of screen time per day 
for both parents and offspring [34].
In a prospective cohort study in England of a fam-
ily-based behavioral treatment in 33 families with 
severely obese children aged 8 to 13 years, the fami-
lies were advised to practice self-monitoring, keep-
ing daily food and activity records, goal setting, pos-
itive reinforcement, and stimulus control to modify 
the child’s eating and exercise behaviors. Foods were 
categorized into “traffic light” food colors of red, yel-
low, and green foods; physical activity aspects were 
also advised. Severely obese children were reported 
to have lost 8.4% of BMI over three months, main-
tained at the three-month follow-up. Self-esteem 
and depression also improved significantly [35].
A study concerning the relationship between pa-
renting style and development of obesity in children 
showed that authoritarian parenting is highly asso-
ciated with the risk of being overweight among 
young children [24]. 
Interviews performed in children with obesity and 
parents with obese children revealed that a lifestyle 
behavior improvement program benefits from pa-
rental support and needs help from family, peers, 
and friends [36]. The studied children with obesity 
benefited from the persistent involvement of sup-
portive persons in the maintenance of lifestyle be-
havior changes. The respondents expected to achieve 
weight reduction by physical activity or eating 
healthy meals. The parents reported struggling with 
adopting new rules and insufficient support from 
family members. Children reported suffering from 
inconsistent parenting and low support from their 
parents. Their experience of bullying at school was 
an obstacle to their ability to achieve the necessary 
changes. Support from peers stimulated their progress. 
Parents identified that the general practitioner is re-
quired to discuss overweight in a non-offensive 
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manner and to present interest in the process of 
weight reduction. The general practitioner should 
play a more supportive role [36].
The Oklahoma Chapter of the American Academy 
of Pediatrics Obesity Committee developed a re-
source toolkit for pediatric primary care providers to 
be used in behavioral counseling of obese children. 
Eight topics were selected for the handouts: sug-
ars-sweetened beverages, daily screen time, sleep, 
proper breakfast, family mealtime, physical activity, 
balanced meals, and food quality. The resource tool-
kit sets four steps, utilizing motivational interview-
ing techniques, to assist with facilitating behavior 
change: 1) obtaining patient history, 2) discussing 
health habits and the family’s reasons for changing 
habits, 3) setting a realistic goal for change, and 4) 
realizing goals. This handout also provides a patient 
questionnaire on health habits to assist with the 
identification of behaviors to be changed, eight pro-
vider and parent handouts on healthy behaviors, and 
a motivational interviewing guide [37].
Behavioral interventions target lifestyle change 
(e.g., counseling on diet, increasing physical activity 
or decreasing sedentary behavior, and addressing 
behavior change) to limit weight gain or decrease 
weight [38]. Effective behavioral interventions in-
clude parental support and the delivery of basic in-
structive information on healthy nutrition and phys-
ical activity. Additional components of the most ef-
fective interventions include the following: 1) being 
conducted in a specialty setting; 2) targeting both 
children and their parents; 3) helping parents and 
children engage in stimulus control (e.g., limiting 
access to tempting foods and limiting screen time); 
and 4) assisting participants in identifying goals, 
self-monitoring, and problem solving to accomplish 
their selected goals. Other common components in-
clude contingent use of rewards or reinforcement, 
motivational interviewing, teaching of coping skills, 
addressing body image, and the option of individual–
family counseling to address family-specific issues. 
All of the effective studies have emphasized eating 
healthy foods and using moderate portions.
The distinguishing characteristics of compre-
hensive multidisciplinary interventions are in-
creased intensity of behavioral change strategies, 
greater frequency of patient–provider contact, and 
involvement of specialists in the treatment. Formalized 
behavioral therapy and a multidisciplinary treat-
ment team exceed the capacity of the services most 
primary care providers can supply.
Systematic evaluation of body measurements, di-
etary intake, and physical activity should be con-
ducted at baseline and at specific intervals through-
out a program. For the implementation of a compre-
hensive multidisciplinary intervention, the compre-
hensive treatment should be provided by a multi-
disciplinary obesity care team, including a behav-
ioral counselor (for example, social worker, psychol-
ogist, other mental health care provider, or trained 
nurse practitioner), registered dietitian, and exercise 
specialist (physical activity specialist or another 
team member with training or a community pro-
gram prepared to assist children with obesity). 
2-3. We recommend that pharmacotherapy and 
bariatric surgery be considered only in patients with 
morbid obesity with major comorbidities after a for-
mal program of intensive lifestyle modification has 
failed. (Strength of evidence, V; grade of recom-
mendation, A, based on committee voting)
Pharmacotherapy should only be performed in ac-
cordance with lifestyle modification [39]. The pre-
scription of weight-reducing medicines used off-label 
to adolescents under 16 years of age should be dis-
couraged for the following reasons: 1) the lack of Food 
and Drug Administration (FDA) approval, 2) in-
sufficient number of safety and efficacy studies per-
formed in children and adolescents with obesity, 3) 
limited efficacy for most agents, and 4) the problem of 
drug-induced adverse reaction related with potential 
obesity-related morbidity and mortality. For obese 
youth who are unable to achieve sufficient weight loss 
with lifestyle interventions alone, adjunctive use of 
more intensive treatments, including pharmacother-
apy, may be appropriate. However, the search for obe-
sity medications that are proved to be safe for 
long-term use, efficacious to promote sufficient weight 
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reduction, and have a good risk–benefit ratio remains 
fruitless. Nevertheless, there is great hope in the suc-
cessful development of more effective, etiology-based 
anti-obesity therapies for children and adults. 
FDA-approved pharmacotherapy for obesity 
should be administered only with a concomitant life-
style modification program of the highest intensity 
available, and only by clinicians who are experienced 
in the use of anti-obesity agents and aware of their 
risk for adverse reactions [40]. Medication should be 
discontinued, and the patient re-evaluated, if the re-
duction in BMI or BMI z score is less than 4% after an-
ti-obesity medication for 12 weeks at full dosage [11].
In adolescents with extreme obesity, clinicians 
may consider bariatric procedures if the patient 
shows poor response to medical treatment for 
weight loss. Indications for bariatric surgery include 
BMI of ＞35 kg/m2, accompanying comorbidities of 
obesity such as type 2 DM, moderate-to-extreme 
sleep apnea, pseudotumor cerebri, debilitating or-
thopedic problems, and non-alcoholic steatohepati-
tis with advanced fibrosis. Another candidate profile 
for bariatric surgery is a BMI of ＞40 kg/m2 with mild 
comorbidities (hypertension, dyslipidemia, moder-
ate orthopedic problems, mild sleep apnea, non-al-
coholic steatohepatitis, and extreme psychological 
distress that is secondary to the obesity) [41,42].
3. Behavioral intervention for children and 
adolescents with obesity: Diet
3-1. We recommend the decrease in intake of sug-
ar-sweetened beverages. (Strength of evidence, I; 
grade of recommendation, A)
3-2. We recommend the reduction in total energy 
intake. (Strength of evidence, I; grade of recom-
mendation, A)
3-3. We suggest the use of small-sized plates or 
bowls. (Strength of evidence, III; grade of recom-
mendation, C)
3-4. We suggest the decrease in consumption of fast 
food. (Strength of evidence, III; grade of recom-
mendation, C)
3-1. We recommend the decrease in intake of 
sugar-sweetened beverages. (Strength of evidence, 
I; grade of recommendation, A)
The Korean National Health and Nutrition 
Examination Survey performed between 2008 and 
2011 revealed that the mean amount of daily sug-
ar-sweetened beverage consumption was 98.7 
mL/day in school children, which tended to increase 
with age [43]. This Korean study revealed that over-
weight and obesity are significantly associated with 
high sugar-sweetened beverage intake among boys 
aged 7 to 12 years (odds ratio, 1.72) [43]. A random-
ized trial performed in adolescents aged 13 to 18 
years demonstrated that BMI changes are sig-
nificant between a sugar-sweetened beverage re-
stricted group and a control group among subjects in 
the upper-baseline BMI percentile [44]. A more re-
cent randomized trial that investigated the effects of 
an intervention designed to decrease consumption 
of sugar-sweetened beverages on weight gain 
showed significant differences in the BMI changes 
between the intervention group and control group at 
both one and two years among Hispanic adolescents 
[45]. Similar to the results from studies in older chil-
dren, sugar-sweetened beverage consumption has 
been positively associated with BMI z scores in chil-
dren at four and five years in a large-scale, longi-
tudinal cohort study [46]. A recent systematic review 
revealed a significant positive association between 
sugar-sweetened beverage consumption and total 
adiposity among children under 12 years old [47]. A 
cross-sectional analysis of children’s dietary data re-
ported that sugar-sweetened beverage intake is in-
dependently associated with alterations in lipid pro-
files, increased markers of inflammation, and in-
creased waist circumference [48].
3-2. We recommend the reduction in total energy 
intake. (Strength of evidence, I; grade of recom-
mendation, A)
Current evidence suggests that weight status can 
be improved in overweight or obese children and 
adolescents by a reduced-energy diet. However, the 
association between weight improvement and mac-
www.pghn.org　　　　11
Dae Yong Yi, et al：Guideline for the Diagnosis and Treatment of Pediatric Obesity
ronutrient distribution of a reduced-energy diet is 
controversial in children and adolescents [49]. 
In an adult systemic review, the overweight and 
obese population who consumed low glycemic index 
food lost more weight and showed better improve-
ment in lipid profiles [50]. A pediatric systematic re-
view comparing low glycemic index/low glycemic 
load with high glycemic index/high glycemic load di-
ets did not reveal the effect of weight loss; however, it 
reported decreases in serum triglyceride and 
Homeostasis Model Assessment (HOMA) index [51]. 
Meanwhile, studies on the association between 
eating quickly and overweight/obesity have showed 
conflicting results. Several cohort studies conducted 
in Japan have demonstrated that eating quickly is 
significantly associated with overweight in girls 
[52,53]. A population-based study conducted in 
Portugal reported no significant association between 
eating quickly and overweight/obesity [54]. 
There is weak evidence regarding the association 
between breakfast intake and obesity [55-58]. 
Likewise, current evidence does not show that the 
consumption of fruits and vegetable is associated 
with overweight and obesity in children and adoles-
cents [59,60]. In an adult study, energy density in-
dependently affects energy intake; however, data are 
lacking for children and adolescents [61].
3-3. We suggest the use of small-sized plates or 
bowls. (Strength of evidence, III; grade of recom-
mendation, C)
Systematic reviews in adults have consistently 
shown that energy intake increases with larger por-
tion sizes [61]. A recent systematic review showed 
that children also consistently consume more food 
and drink when offered larger-sized portions, pack-
ages, or tableware than when offered smaller-sized 
versions [62]. Total calorie consumption reportedly 
decreases in those receiving small portion sizes 
among children under six years of age [63,64]. A re-
cent observational study revealed that reduced por-
tion sizes are associated with BMI reduction after one 
and two years among children and adolescents [65].
3-4. We suggest the decrease in consumption of 
fast food. (Strength of evidence, III; grade of recom-
mendation, C)
The intake of fast food has an effect on overweight 
and obesity in school children and adolescents. 
Composition data from leading fast food company 
websites show that fast foods have very high energy 
density [66,67]. A Korean nationwide observational 
study performed in 2001 reported contrasting results 
regarding the association between fast food intake 
and overweight and obesity [68]. However, a recent 
large-scale observational study performed in Jeju 
Island revealed that obese children had significantly 
higher rates of fast food consumption [69]. 
4. Behavioral intervention for children and 
adolescents with obesity: Exercise
4-1. We recommend physical activity, which is ben-
eficial to all children and adolescents. (Strength of 
evidence, I; grade of recommendation, A)
4-2. We recommend moderate to vigorous levels of 
physical activity, including regular and steady ex-
ercise, which is helpful in promoting a decrease in 
weight. The recommended duration of moderate 
tovigorous exercise is at least 20 minutes, with a 
goal of 60 minutes, five days per week. (Strength of 
evidence, I; grade of recommendation, A)
4-3. We recommend programmed exercises, which 
are helpful in reducing body fat in children and 
adolescents. (Strength of evidence, I; grade of rec-
ommendation, A)
4-1. Physical activity is beneficial to all children 
and adolescents. (Strength of evidence, I; grade of 
recommendation, A)
Physical activity is especially effective in enhanc-
ing cardiovascular fitness, decreasing body fat, and 
lowering risk factors for diabetes [70-73]. Apart from 
the benefits for maintaining weight and reducing 
health risks related to childhood obesity, physical ac-
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Table 3. Stepwise Exercise Strategies according to Age and Obesity Status
Age group Obesity status First intervention step Advanced intervention step
Infant (<2 y) Weight for height ≥95th percentile Prevention counselling Prevention counselling
Early childhood 
(2-5 y)
BMI 5th-84th percentile 
BMI 85th-94th percentile with no risks
Prevention counselling Prevention counselling
BMI 85th-94th percentile with risks Step 1 Step 2
BMI ≥95th percentile Step 1 Step 3
Middle childhood 
(6-11 y)
BMI 5th-84th percentile
BMI 85th-94th percentile with no risks
Prevention counselling Prevention counselling
BMI 85th-94th percentile with risks Step 1 Step 2
BMI 95th-99th percentile Step 1 Step 3
BMI ＞99th percentile Step 1
Step 2 or 3, if family is motivated
Step 4, if appropriate
Adolescence 
(12-18 y)
BMI 5th-84th percentile
BMI 85th-94th percentile with no risks
Prevention counselling Prevention counselling
BMI 85th-94th percentile with risks Step 1 Step 2
BMI 95th-99th percentile Step 1
BMI ＞99th percentile Step 1
Step 2 or 3 if patient and 
family are motivated
Step 4, if appropriate
Step 1: Prevention plus management; Be physically active ≥1 hour each day. Young children: unstructured play in young children.
Older children: should find physical activities that they enjoy.
Step 2: Structured weight management; Planned, supervised, physical activity or active play for 60 minutes per day.
Step 3: Comprehensive multidisciplinary management; Physical activity goal setting, and contingency management. Negative energy
balance resulting from structured physical activity changes is planned. Multidisciplinary team with experience in childhood obesity
including exercise specialist.
Step 4: Tertiary care management.
BMI: body mass index.
tivity may prove to enhance aspects of children’s 
brain activation, including cognitive development 
[74,75]. Therefore, the WHO, American Alliance for 
Health, Physical Education, Recreation and Dance, 
British Association of Sport and Exercise Medicine, 
and Canadian Academy of Sport and Exercise 
Medicine recommend for children to participate in 
physical activities as early as possible. Guidelines 
that recommend suitable physical activities for each 
age group have also been formulated in developed 
countries.
1) Children and youth aged 5 to17 years should ac-
cumulate at least 60 minutes of moderate- to vigo-
rous-intensity physical activity daily.
2) Physical activity greater than 60 minutes in du-
ration provide more health benefits.
3) Most of the daily physical activity should be 
aerobic. Vigorous-intensity activities should be in-
corporated, including those that strengthen muscle 
and bone, and performed at least three times per 
week.
4-2. Moderate to vigorous levels of physical activ-
ity, including regular and steady exercise, are help-
ful in promoting a decrease in weight. (Strength of 
evidence, I; grade of recommendation, A)
Regular exercises improve weight and BMI, as 
well as blood sugar and triglyceride levels [70, 
76-78]. The degree of weight loss is maximized when 
exercise is combined with decreased calorie intake, 
which is also helpful in sustaining improved weight 
after weight loss. The degree of weight loss is mini-
mal in the absence of calorie intake restriction.
Moderate exercise refers to exercise that causes 
mild increases in breathing and heart rate [71,74]. In 
other words, conversation is doable during moderate 
exercise, whereas singing is difficult to perform 
simultaneously. Brisk walking, cycling, and practice 
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in such sports as soccer, basketball, and badminton, 
are examples of moderate exercise. Meanwhile, con-
versation is difficult and singing impossible during 
vigorous exercise, owing to significant increases in 
breathing and heart rate. Running fast, jump rope 
workout, inline skating, and playing a game of soc-
cer, basketball, or badminton are examples of vigo-
rous exercise. At least 20 minutes of moderate ex-
ercise is recommended, with a goal of 60 minutes, 
five days per week, whereas vigorous exercise is ef-
fective when done three times per week [75,79,80].
4-3. Programmed exercises are helpful in reducing 
body fat in children and adolescents. (Strength of 
evidence, I; grade of recommendation, A)
The effect of exercise programs is maximized with 
the involvement of a specialist to instruct the activity 
or when friends or family members participate in to-
gether [81-83]. The type, frequency, intensity, and 
duration of exercises should be included in the pre-
scription of the program. Moreover, prescriptions for 
resistance training programs should be in-
dividualized to stimulate all of the major muscle 
groups and use all of the muscle groups [72]. 
In addition, exercise intensity should be adjusted 
stepwise according to age and BMI, rather than en-
gaging in high-level exercise from the beginning 
[14]. Especially in patients with high-level obesity, 
weight-bearing exercise, such as excessive jump 
rope, should be avoided because repeated impact 
may be applied to parts such as knees, ankles, and 
hip joints (Table 3). However, according to a recent 
meta-analysis that investigated the impact of phys-
ical education on obesity prevention in children, 
adolescents, and adults, although physical educa-
tion has positive effects on obesity-related body in-
dices and health status, its effect is statistically 
insignificant. Moreover, there is lack of evidence 
based on data [72].
5. Behavioral intervention for children and 
adolescents with obesity: Lifestyle 
5-1. We recommend increasing physical activity 
and limiting sedentary time (non-academic screen 
time, digital activities) to one to two hours per day 
for weight reduction. (Strength of evidence, I; 
grade of recommendation, A)
5-2. We recommend maintaining adequate sleep 
duration for the prevention of obesity in children 
and adolescents. (Strength of evidence, I; grade of 
recommendation, A)
5-3. We recommend a family-centered approach, 
including parents, to prevent and treat children’s 
obesity effectively; parental obesogenic lifestyle 
habits are related to children’s obesity. (Strength of 
evidence, I; grade of recommendation, A)
5-4. We recommend the development of specific 
public health interventions as essential to over-
weight and obesity control in children with lower 
socioeconomic status (SES). (Strength of evidence, 
I; grade of recommendation, A) 
5-5. We recommend that obesity interventions be 
conducted in multiple key childhood environ-
ments, including family, school, and community. 
(Strength of evidence, I; grade of recommendation, A)
5-1. We recommend increasing physical activity 
and limiting sedentary time (non-academic screen 
time, digital activities) to one to two hours per day 
for weight reduction. (Strength of evidence, I; grade 
of recommendation, A)
Obese children tend to commute to school by 
school bus rather than walk to school [84-86]. The 
sedentariness of obese children is higher than that in 
normally weighted children; the former have been 
shown to like to lie down when staying indoors and 
use the elevators more than stairs [84,87,88]. Obese 
children spend a high proportion of their day watch-
ing television or using the personal computer com-
pared with normally weighted children [84,89-91]. 
Increased television-viewing time decreases physical 
activity, and can increase the consumption of 
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high-calorie diet through being exposed to television 
commercials of high-calorie foods, such as fast food, 
snack, and soft drinks [84,92-96]. The effort to walk 
as much as possible and exercise regularly is sig-
nificantly related to losing body weight [86]. 
5-2. We recommend maintaining adequate sleep 
duration for the prevention of obesity in children 
and adolescents. (Strength of evidence, I; grade of 
recommendation, A)
A school-based, cross-sectional study of 3,785 
Korean adolescents in middle and high school be-
tween the ages of 11 and 18 years showed the sig-
nificant association of longer sleep duration on both 
week day and weekends with decreased BMI for 
both sexes [97]. A study using data of 489 adoles-
cents aged 12 to 18 years from the Korean National 
Health and Nutrition Examination Survey from 2013 
to 2014 showed that the risk of obesity decreases 
with increased sleep duration [98]. Researches in 
Canada, Japan, and China showed an inverse corre-
lation between sleep duration and obesity in chil-
dren [98-101].
Sleep restriction results in significant increases in 
caloric intake [102,103]. Short sleep is associated 
with decreased moderate to vigorous physical activ-
ity and increased sedentary time [102,104]. A sig-
nificant negative association has been observed be-
tween sleep duration and screen time [102,105]. 
Short sleep is also associated with insulin resistance 
[102]. 
5-3. We recommend a family-centered approach, 
including parents, to prevent and treat children’s 
obesity effectively; parental obesogenic lifestyle 
habits are related to children’s obesity. (Strength of 
evidence, I; grade of recommendation, A)
According to a meta-analysis conducted with 
studies published between 2000 and 2009, the ma-
jority of studies (70%) have shown statistically sig-
nificant moderate to large effect size changes in child 
BMI after participation in a family-based inter-
vention for weight loss. Of these, 50% reported stat-
istically significant weight loss changes at six- 
month, one-year, and two-year follow-up, albeit 
with small to moderate effect sizes [106].
In a study of Korean first-grade elementary school 
students and their parents, parental lifestyle habits 
were shown to induce children’s obesity [107]. 
Children of obese parents are more likely to be diag-
nosed as overweight compared with children of nor-
mal-weight parents. Among the paternal lifestyle 
habits, hours of watching television or computer us-
age, and consumption frequency of soda, ice cream, 
cake, and chips are related to the children being 
overweight. Among the maternal lifestyle habits, 
hours of watching television or computer usage, fre-
quency of eating breakfast, and frequency of over-
eating are related to the children being overweight. 
Parents’ lifestyle habits can affect children’s weight 
via an effect on the children’s lifestyle habits. The de-
gree of obesity between parents and children tends 
to be similar because parents and children share not 
only genes but also the same family environment. 
Family environment plays an important role in 
forming children’s lifestyle, including eating habits 
and physical activity through parents’ lifestyles. As 
the mother tends to take the main role in rearing 
children, maternal obesogenic lifestyles have greater 
influence on children’s obesity.
5-4. We recommend the development of specific 
public health interventions as essential for over-
weight and obesity control in children with lower 
SES. (Strength of evidence, I; grade of recom-
mendation, A)
According to a study based on data of the Korea 
National Health and Nutrition Examination Survey 
2007-2010 conducted by the Korea Centers for 
Disease Control and Prevention, SES does not affect 
the observed relationships of overweight or obesity 
in children aged 2 to 18 years [108]. However, recent 
published systematic reviews and meta-analyses 
have showed that children with lower SES have 
higher risks of being diagnosed with overweight and 
obesity [109,110]. Another systematic review and 
meta-analysis of studies published between 1990 
and 2014 showed that low SES is associated with a 
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10% higher risk of overweight and a 41% higher risk 
of obesity in children aged 0 to 15 years [109]. In a 
subgroup analysis, this relationship was prominent 
in high-income countries and in more economic de-
veloped areas, including North America, Europe, and 
Oceania [109]. Another systematic review to de-
scribe the relationship between SES and child-
hood/adolescent weight status in papers published 
in rich countries from 1990 through 2013 showed a 
predominantly inverse relationship [110].
Adolescents from areas with low SES more often 
skipped breakfast and more often ate snacks com-
pared with adolescents from high SES areas 
[111,112]. SES has been positively associated with 
food frequency intake scores in both sexes. 
Adolescents with low SES tended to show an irregu-
lar meal pattern [31,33]. High household SES is also 
associated with increased intakes of vegetables, 
fruits, and dietary fiber, and with decreased intakes 
of fat [111,113,114].
A study on the association among parental socio-
economic level, overweight, and eating habits with 
diet quality in Korean sixth-grade school children 
showed that a lower SES (in terms of parental in-
come or parental education level) relates to the con-
sumption of significantly fewer fruits [111]. In the 
same study, the children in the lower socioeconomic 
group had a lower food habit score (high frequency 
of breakfast skipping and ramen noodle con-
sumption), diet quality, and intake of nutrients com-
pared with those in the higher socioeconomic group. 
Lower maternal education status is also associated 
with a higher risk for being overweight in girls. 
Specific public health interventions should support 
parents and children with lower SES to develop 
health-related behaviors that may prevent child-
hood obesity. 
5-5. We recommend that obesity interventions be 
conducted in multiple key childhood environments, 
including the family, school, and community. 
(Strength of evidence, I; grade of recommendation, A)
Most strategies for preventing or reducing child-
hood obesity have focused on individual behavior 
modification with limited success [115,116]. The en-
vironment of children with obesity, including fam-
ily, schools, after-school programs, and community, 
as well as the policy level, can be changed to promote 
healthier lifestyles through multi-level obesity inter-
ventions [115,117]. The family represents the closest 
environment of children; thus, the family is im-
portant to forming the healthy lifestyle of children 
[115,107]. School is the place where students spend 
most of their time beginning with the time they 
reach schooling age [115,118]. Children can main-
tain and manage a healthy lifestyle through teacher–
pupil interaction and peer interaction [115,118]. In 
the treatment or prevention of childhood obesity, a 
variety of support systems through parents, peers, 
and teacher relationships can induce changes in the 
overall environment surrounding children, thereby 
raising the effectiveness of any obesity intervention 
[115]. Multidisciplinary interventions can make 
obese children continue a healthy lifestyle [115]. 
Obesity in children and adolescents is linked to adult 
obesity and various diseases, leading to an increase 
in public medical expenses. Therefore, national poli-
cy is needed in leading efforts to preventing obesity 
fundamentally and to establishing education and 
policy for health promotion.
6. Behavioral intervention for children and 
adolescents with obesity: Mental health
6-1. We recommend that obese children be moni-
tored for psychological problems and screened for 
the need for psychiatric treatment. (Strength of 
evidence, I; grade of recommendation, A). 
6-2. We recommend that physicians emphasize 
family functioning and let the family participate in 
the treatment of the obese child. (Strength of evi-
dence, I; grade of recommendation, A). 
6-3. We recommend cognitive behavioral therapy, 
which may be beneficial to treating child obesity. 
(Strength of evidence, III; grade of recom-
mendation, C)
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6-1. We recommend that obese children be moni-
tored for psychological problems and screened for 
the need for psychiatric treatment. (Strength of evi-
dence, I; grade of recommendation, A)
Obese children may be suffering from low self-es-
teem, body shape dissatisfaction, depression, eating 
disorder, obesity stigma, teasing, or bullying by peers 
[119-125]. They also live with significantly lower 
health-related quality of life compared with normal 
weighing children, or several pediatric chronic dis-
eases [126]. Obese children complain of a low quality 
of life associated with physical and psychosocial 
health, and emotional, social, and school function-
ing [126,127]. 
Extremely obese adolescents have higher rates of 
mood, anxiety, somatoform, and eating disorders com-
pared with a population-based control group [128]. 
The screening tools for psychological problems include 
the Korean-Child Behavior Checklist, Children’s 
Depression Inventory, Korean version of the Eating 
Attitude Test-26, somatotype drawings, and Pediatric 
Quality of Life Inventory [121-123,126,127].
6-2. We recommend that physicians emphasize 
family functioning and let the family participate in 
the treatment of the obese child. (Strength of evi-
dence, I; grade of recommendation, A)
Poor family functioning is associated with in-
creased risk of obesity and overweight [129,130]. 
The elements of poor family functioning related to 
obesity are poor communication, poor behavior con-
trol, high levels of family conflict, and low family hi-
erarchy values [130]. Although standardized family 
functioning measures are necessary, half of the iden-
tified intervention studies reported a significant re-
lationship between family functioning and changes 
in child weight [130]. Contrary to these reports, sev-
eral studies have reported that family functioning is 
not associated with child obesity; rather, an over-
weight mother is largely linked to child obesity 
[131,132]. Given the high correlation of parental or 
mother’s obesity with child obesity, parental behav-
ior changes in the family should be considered 
[132,133]. Family-based treatment is crucial to con-
trol nip successfully child obesity.
6-3. We suggest cognitive behavioral therapy, 
which might be beneficial to treating child obesity. 
(Strength of evidence, III; grade of recommendation, 
C)
Cognitive behavioral therapy (CBT) is effective in 
treating childhood obesity [134-136]. The treatment 
goal is weight control by healthy changes in lifestyle 
rather than weight reduction. The key element of 
this therapy is self-regulation, with techniques in-
cluding learning self-instructions (e.g., “stop and 
think”), self-observation, self-evaluation, and self- 
reward [136]. To train self-regulation skills, model-
ing (showing the coping skills to the child), behavior 
rehearsal, and homework have been used [136]. 
Coping skills are taught for different stressful sit-
uations (e.g., feeling alone) and relapse moments 
(e.g., feeling hungry) [134,135]. The progression of 
CBT is concentrated on one new small change in food 
and exercise behavior (e.g., drinking water instead 
of soft drinks, walking instead of taking the car) 
[135,136]. Self-monitoring—recording one’s behav-
ior—is perhaps the most important component of be-
havioral treatment. Patients keep detailed records of 
their food intake, physical activity, and body weight, 
which they review with their interventionist to iden-
tify areas of success and for improvement [137].
Parents participate in CBT as helpers. For the stim-
ulus control of the obese child, parents are taught the 
importance of ending restrictions on the places and 
times for eating. Motivation of the obese child is en-
hanced by allowing his or her own choices in plan-
ning the program and using a child-friendly ap-
proach with respect to developmental demands; for 
example, providing activities involving cooking, 
moving, and playing [134,135]. Braet and Van 
Winckel [135] reported that in the long-term fol-
low-up over 4.6 years, 71.6% subjects treated with 
CBT showed no further increase in percentage 
overweight.
Negative body image is a major concern of over-
weight persons. CBT includes the information to 
change negative stereotypes of obesity, modification 
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of intrusive thoughts of body dissatisfaction and 
overvalued beliefs regarding physical appearance, 
exposure to avoided body image situations, and 
elimination of body checking. CBT has significantly 
improved the body image, psychological symptoms, 
self-esteem, overeating, and guilt eating in obese 
subjects [138].
7. Pharmacotherapy of children and 
adolescents with obesity
7-1. We recommend that pharmacologic treatment 
is not used as a primary treatment nor sole therapy 
mode in pediatric obesity. (Strength of evidence, I; 
grade of recommendation, A)
7-2. We recommend that the response and adverse 
reaction to pharmacologic treatment be monitored 
closely. The decision to continue or discontinue 
should be made by accounting for the monitoring 
result. (Strength of evidence, V; grade of recom-
mendation, A, based on committee voting)
7-1. We recommend that pharmacologic treat-
ment not be used as a primary treatment nor lone 
therapy method in pediatric obesity. (Strength of 
evidence, I; grade of recommendation, A)
Only a few studies have been conducted in phar-
macologic treatment for childhood obesity. In a 
pre-pubertal age group (younger than 12 years old), 
the effectiveness and safety of pharmacologic treat-
ment of obesity are low because of issues of appro-
priate dosage, safety, adverse event, and ethical as-
pects [139,140]. Research data on adolescents over 
the age of 12 years are not sufficiently accumulated 
as well. However, some weight loss effects could be 
expected [139-141]. Therefore, in case of primary 
treatment failure, an approved drug could be consid-
ered added, along with behavioral intervention.
Orlistat, metformin, glucagon-like peptide 1 
(GLP-1) agonists, and topiramate are available in 
adult obesity, and there have been a considerable 
number of efforts to use these agents in childhood 
obesity [142-146]. Orlistat is the only drug that the 
FDA has approved for childhood obesity over the age 
of 12 years, but it is not recommended to use as a pri-
mary nor single therapy [141,147]. Data on the sin-
gle drug use of orlistat without behavioral therapy 
are not available. In case of concerns on side effects, 
only behavioral therapy is recommended, instead of 
adding drugs.
1) Orlistat
Orlistat, a fat absorption inhibitor, is the only 
agent that the Korea Food and Drug Administration 
had approved for long-term use (one year) for 
weight control in pediatric obesity [148]. It is the on-
ly FDA-approved drug that can be prescribed three 
times a day for childhood obesity in children aged 12 
to 16 years [142,147]. However, it is not recom-
mended as a primary treatment for weight control in 
childhood obesity, especially between the ages of 2 
and 11 years [140,149]. Orlistat inhibits lipid diges-
tion by the suppression of pancreatic and gastric 
lipase. The decreased lipase activity in the gastro-
intestinal tract hinders consumed fat to be absorbed 
as a form of fatty acids and monoglycerols. Fat thus 
remains in the stool in triglyceride form [150]. A pla-
cebo controlled study of obese children aged 12 to 16 
years showed a significant reduction in BMI com-
pared with the controls, but also reported significant 
side effects. Another study among obese teenagers 
aged 14 to 18 years failed to show significant weight 
loss [151].
Orlistat should be taken with meals, which makes 
it difficult to prescribe to school-aged children. In 
some reports, orlistat interferes with the absorption 
of fat-soluble vitamins, such as vitamins E and D 
[141]. For many obesity-control drugs proven safe 
and effective for long-term use in adults, pediatric 
data are limited. Orlistat may cause adverse effects, 
such as steatorrhea, soiling, bloating, and increased 
number of bowel movement. Such adverse events 
have been reported in pediatric use. Younger pa-
tients are recommended to take multivitamins be-
cause orlistat can hinder the absorption of fat-solu-
ble vitamins, such as vitamins A, K, and β-carotene. 
There have also been rare reports of hepatic and renal 
damage in adults, and of oxalate nephrolithiasis and 
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oxalate nephropathy with renal failure [152]. 
2) Metformin
Metformin can be used safely in type 2 DM chil-
dren over the age of 10 years and has been known to 
result in weight loss. It can be used at about 1,500 mg 
a day in children with type 2 DM between the ages of 
12 to 14 years with BMI of 26 to 40 kg/m2 [153]. 
Although metformin can be used by type 2 DM chil-
dren, it is not recommended as treatment for only 
obesity; indeed, it has not been FDA approved as an 
obesity treatment [154-156]. Metformin reduces 
hepatic glucose production, increases peripheral in-
sulin sensitivity, and lowers appetite [157].
A study has shown BMI reduction after 6 to 12 
months of use of metformin. A previous study re-
ported that metformin has some effects in children 
with insulin resistance [158]. Although metformin 
could be used in the short term, along with behav-
ioral therapy, it is not recommended as a single drug 
for obesity treatment because of the limited effect of 
weight control [11].
3) Liraglutide
Liraglutide is a GLP 1 analog that can be used for 
long-term treatment of adult obesity [11]. GLP-1 is 
the incretin hormone released by the ileal L-cells af-
ter food consumption, inducing satiety by delaying 
gastric emptying and glucagon secretion. It also con-
trols appetite and satiety in the hypothalamus 
[141,149]. In adult type 2 DM, GLP-1 is an effective 
primary therapy for controlling HbA1c and weight. 
For obesity in adolescents, a significant decrease in 
BMI has been observed after three months of use 
[11,142]. 
Liraglutide needs to be injected daily, which can be 
a limitation in pediatric application. Safety and phar-
macokinetics have been tested in children with type 
2 DM aged between 10 and 17 years: it has similar ef-
fects as in adults. However, about half of the subjects 
experienced at least one side effect [159]. Among 
GLP-1’s side effects are nausea, vomiting, diarrhea, 
and low blood glucoses. However, rare but serious 
side effects have also been reported, such as kidney 
failure, suicidal impulse, pancreatitis, and gall-
bladder disease [152]. Therefore, it is not recom-
mended to use liraglutide for childhood obesity 
treatment.
4) Topiramate
Topiramate is a gamma-aminobutyric acid re-
ceptor antagonist that is known to be a treatment for 
epilepsy (for those aged 2 years and older) and mi-
graine (for those aged 12 years and older). The 
weight loss effect of zonisamide (voltage-dependent 
sodium channels and T-type calcium blocker) was 
observed in the study of epilepsy, which might be re-
lated with the serotonin effect [141,152,153]. 
Despite the weight control effect of topiramate and 
zonisamide, the findings of epilepsy studies cannot 
be directly generalized into simple treatment for 
childhood obesity [149].
No proven safety or efficacy data are available with 
combined therapy of phentermine-topiramate in pe-
diatric obesity [152]. The effect of zonisamide in pe-
diatric obesity was reported in case reports of limited 
subjects [153]. Headache, nausea, vomiting, thirst, 
decreased appetite, abdominal pain, anxiety, speech 
disorders, attention and memory deficit, somno-
lence, and diarrhea have been associated with top-
iramate and zonisamide [143,144,146]. Serious side 
effects were reported in children using topiramate, 
such as glaucoma, stroke, metabolic acidosis, cogni-
tive disorders, hyperammonianemia, encephalop-
athy, and kidney stone [152]. Therefore, it is not rec-
ommended to use topiramate for the treatment of 
childhood obesity.
7-2. We recommend that the response and ad-
verse reaction of pharmacologic treatment be moni-
tored closely. The decision to continue or dis-
continue treatment should be made with consid-
eration for the monitoring result. (Strength of evi-
dence, V; grade of recommendation, A, based on 
commiitte voting)
Although cumulative data on the effectiveness of 
pharmacologic treatment of childhood obesity are 
insufficient, reports of adverse reactions related to 
those agents exist in many references, including 
adults’ studies [11,141,150,152,160]. Therefore, 
pharmacologic treatment of childhood obesity 
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should be taken cautiously, and careful observation 
and evaluation of its adverse reactions and effects 
are essential.
8. Bariatric surgery for children and 
adolescents with obesity
8-1. We recommend that bariatric surgery be an ap-
propriate option to improve health when adoles-
cents with a BMI ＞40 kg/m2 or ＞35 kg/m2 and 
obesity-related comorbidities fail to respond to be-
havioral interventions (with or without pharmaco-
therapy) for sufficient weight loss to achieve tar-
geted health outcome goals and when they attain 
Tanner 4 or 5 pubertal development and final or 
near-final adult height. (Strength of evidence, V; 
grade of recommendation, A, based on committee 
voting)
The timing for surgical treatment of extremely 
obese adolescents remains controversial and de-
pends, in most cases, on the compelling health needs 
of the patient [82]. Physiologic maturation is gen-
erally complete by sexual maturation (Tanner) stage 
4. Bariatric surgery is considered only under the fol-
lowing conditions: when the patient has attained 
Tanner 4 or 5 pubertal development and final or 
near-final adult height, BMI ＞35 kg/m2 with major 
comorbidities (type 2 DM, moderate to severe sleep 
apnea of apnea-hypotonia index ＞15, pseudotumor 
cerebri, and severe non-alcoholic steatohepatitis) or 
BMI ＞40 kg/m2 with other comorbidities (hyperten-
sion, insulin resistance, glucose intolerance, dyslipi-
demia, sleep apnea with apnea-hypopnea index ＞5, 
and substantially impaired quality of life or activities 
of daily living). Skeletal maturation (adult stature) is 
normally attained by the age of 13 to 14 years in girls 
and 15 to 16 years in boys. If uncertainty exists on 
whether adult stature has been attained, skeletal 
maturation (bone age) can be objectively assessed 
with a radiograph of the hand and the wrist. From 
this view, bariatric surgery would not be recom-
mended for pre-pubertal adolescents [161,162].
Adolescent psychological development also im-
pacts the ability to participate in surgical deci-
sion-making and postoperative dietary compliance. 
Cognitive development refers to the development of 
the ability to think and reason [163]. 
CONCLUSION
This evidence-based clinical practice guideline on 
the diagnosis and treatment of pediatric obesity in 
children and adolescents in Korea was produced by 
all members of the Pediatric Obesity Committee of 
the KSPGHAN and experts from all related fields.
The most essential concept for the effective treat-
ment of obesity in children and adolescents recom-
mended in this guideline is a family-based, compre-
hensive, multidisciplinary behavioral intervention 
focused on lifestyle modification, including calo-
rie-controlled balanced diet, active vigorous physical 
activity and exercise, and reduction of sedentary 
habits, and support by the entire family, school, and 
community. Evidence for the effectiveness and safe-
ty of most pharmacotherapy and bariatric surgery 
treatments remains limited in adolescents and in-
sufficient in children.
For better outcomes, the prevention and treat-
ment of obesity and obesity-related morbidity 
should be started from early in life to control and 
manage the risks for developing NAFLD, metabolic 
complications, and obesity-related physical and psy-
chosocial comorbidities in childhood, and to reduce 
cardiovascular and metabolic morbidities and pre-
mature mortality later in adulthood as well. As the 
disease burden of obesity on the overall health status 
has become a key issue of health care system world-
wide, including South Korea, this guideline would 
be beneficial not only in clinical practice but also in 
establishing health care policies.
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